The GLP is committed to full transparency. Download and review our 2019 Annual Report

Alzheimer’s blood test edges closer

| | July 31, 2013

For now, there is no definitive test for Alzheimer’s disease. Doctors rely on cognition tests and brain scans. So one of the main goals of Alzheimer’s research is to find ways of detecting the disease earlier.

A new technique published in the journal Genome Biology showed differences in the tiny fragments of genetic material floating in the blood could be used to identify the disease in patients. Early trials showed that the test was successfully “able to distinguish with high diagnostic accuracies between Alzheimer’s disease patients and healthy” people.

Read the full, original story here: Alzheimer’s blood test edges closer

The GLP aggregated and excerpted this article to reflect the diversity of news, opinion, and analysis. Click the link above to read the full, original article.
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend